A clinical-stage biotechnology company developing novel therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system.
Paris, France
Joined May 2016
- Tweets484
- Following97
- Followers1.7K
- Likes217
GenSight Biologics Appoints Sissel Rodahl as Senior Vice-President of Commercial Operations to Lead the Launch of LUMEVOQ® in Europe - businesswire.com/news/home/2…
#genetherapy #biologics #rarediseases #executivepositions #LHON #Ophthalmology
GenSight Biologics Announces Publication of Non-Human Primate Study Reporting Presence of LUMEVOQ® Vector DNA in Contralateral Eyes After Unilateral Injection | Business Wire
businesswire.com/news/home/2…
GenSight Biologics invite Julien Secheyron, « Patient N°15 » de la 1ère étude clinique de LUMEVOQ®, à venir présenter son livre « Vous ne verrez plus »
businesswire.com/news/home/2…
GenSight Biologics reports second patient case showing significant visual recovery after GS030 optogenetic treatment in the PIONEER Phase I/II trial
Patient video on vimeo.com/646472992
#Optogenetics #Ophthalmology #retinitis #blindness #AAO2021
GenSight Biologics Announces Extension of Day 120 Clock Stop of LUMEVOQ® EMA Regulatory Filing; MAA Review to Resume in April 2022 | Business Wire
businesswire.com/news/home/2…
GenSight Biologics Reports Cash Position as of September 30, 2021 and Provides Operational Update | Business Wire
businesswire.com/news/home/2…
GenSight Biologics retweeted
Investigators conducted an optogenetics vision restoration in a man with retinitis pigmentosa who had been blind for decades — here's what they've found: buff.ly/2XaoihT
@UPMC @UniBasel_en @GenSightBio #Ophthalmology #GeneTherapy
GenSight Biologics retweeted
Magali Taiel of @GenSightBio discusses LUMEVOQ #genetherapy for Leber hereditary optic neuropathy
Watch: 👉 ow.ly/BesJ50Grzd9 👈
@alliancerm #CGMesa21 #ophthamology #RegenerativeMedicine
Dr Magali Taiel will present at @alliancerm Cell & Gene Meeting on the Mesa about LUMEVOQ® #genetherapy to treat #lhon #rarediseases #blindness under regulatory review #EMA for European #maa expected in H1 2022
#CGMesa21 #RegenerativeMedicine #retina #ophthalmology
GenSight Biologics retweeted
@LandosBio’s LABP-104 gets Approved for #SLE #treatment.
#NIH Grant of USD 3 million to @AmydisInc for exploring #ASYN.
#USFDA Grant to @GenSightBio’ #GS030 for #RetinitisPigmentosa.
For more details, visit bit.ly/3mOgWtI. (2/2)
#pharma #biotech #news #pharmanews
GenSight Biologics retweeted
Fast track designation for @GenSightBio's gene therapy GS030 businesswire.com/news/home/2…
GenSight Biologics retweeted
La start-up française @GenSightBio a mis au point une thérapie génique qui redonne leur autonomie aux patients atteints de la maladie de Leber, qui rend quasi-aveugle en quelques semaines nouvelobs.com/economie/20211… récit par @domnora
GenSight Biologics retweeted
Investigators conducted an optogenetics vision restoration in a man with retinitis pigmentosa who had been blind for decades — here's what they've found: buff.ly/3DZIHHA
@UPMC @UniBasel_en @GenSightBio #Ophthalmology #GeneTherapy
GenSight Biologics retweeted
@GenSightBio announces that the peer reviewed journal International Ophthalmology Clinics has published a review of all current and past gene therapy trials for LHON. To read more, go to bit.ly/3uOOqfj #Clinicaltrials #LHON
Just published in the peer-reviewed International Ophthalmology Clinics
- Bilateral treatment effect following unilateral injection of #genetherapy independently reported by three research groups
- LUMEVOQ® for #LHON first #genetherapy requesting #maa #EMA
journals.lww.com/internat-op…
GenSight Biologics retweeted
Join us at Chardan 5th Annual Genetic Medicines Conference #ChardanGMConf #CGMC2021
@bernard_gilly to present on Monday Oct. 4, 2021 8.00am ET. Webcast of the fireside chat to be available at bit.ly/3zZOGsM for 90 days
#genetherapy #cellandgenetherapy #rarediseases #LHON
Join us at Chardan 5th Annual Genetic Medicines Conference #ChardanGMConf #CGMC2021
@bernard_gilly to present on Monday Oct. 4, 2021 8.00am ET. Webcast of the fireside chat to be available at bit.ly/3zZOGsM for 90 days
#genetherapy #cellandgenetherapy #rarediseases #LHON
GenSight Biologics retweeted
Investigators conducted an optogenetics vision restoration in a man with retinitis pigmentosa who had been blind for decades — here's what they've found: buff.ly/3ySs7FE
@UPMC @UniBasel_en @GenSightBio #Ophthalmology #GeneTherapy
GenSight Biologics retweeted
Investigators conducted an optogenetics vision restoration in a man with retinitis pigmentosa who had been blind for decades — here's what they've found: buff.ly/38DQ2ht
@UPMC @UniBasel_en @GenSightBio #Ophthalmology #GeneTherapy
GenSight Biologics retweeted
Investigators conducted an optogenetics vision restoration in a man with retinitis pigmentosa who had been blind for decades — here's what they've found: buff.ly/38Jeu0Q
@UPMC @UniBasel_en @GenSightBio #Ophthalmology #GeneTherapy